Alpha Cognition, Inc. is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis.

Immunitybio Inc ( (IBRX)) has released its Q3 earnings. Here is a breakdown of the information Immunitybio Inc presented to its investors. ImmunityBio, Inc. is a biotechnology company focused on ...

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company focusing on adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system, with a ...

The study “tried to capture that invisibility” using a sampling technique known as “capture-recapture”, said lead author ...

First global analysis of diabetes trends finds that while prevalence of the condition has exploded, treatment rates have ...

Researchers using machine learning discovered that variations in microbial load in the gut, influenced by age, sex, diet, and more, play a significant role in disease-related bacterial presence. This ...

Cases have been detected in 14 states, according to an update from the U.S. Centers for Disease Control and Prevention ...

Nathaniel Dye, 38, has incurable cancer and is calling on MPs to legalise assisted dying as a Bill on the issue is set to be ...

Following an absence of 15 months, the H5N1 HPAI virus has been detected again in the far west of Asia in the Republic of ...

The patient, the country’s first presumed human case of H5N1, was previously healthy and had no underlying conditions ...